Sumatriptan-associated ischemic colitis: Case report and review of the literature and FAERS

Drug Safety

Volumn 37, Issue 2, 2014, Pages 109-121

  Nguyen, Thuc Quyen ^a   Lewis, James H ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALOSETRON; ANTIMIGRAINE AGENT; CERTOLIZUMAB PEGOL; CIPROFLOXACIN; COCAINE; CYCLOBENZAPRINE; DICLOFENAC; DIGITALIS; ESOMEPRAZOLE; ESTROGEN; ETANERCEPT; FUROSEMIDE; HYDROMORPHONE; INFLIXIMAB; INTERFERON BETA SERINE; MESALAZINE; METRONIDAZOLE; NAPROXEN; NARATRIPTAN; NARCOTIC AGENT; OLMESARTAN; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; PENTOXIFYLLINE; RIZATRIPTAN; SUMATRIPTAN; TEGASEROD; TRIPTAN DERIVATIVE; UNINDEXED DRUG;

ABDOMINAL DISCOMFORT; ABDOMINAL TENDERNESS; ACUTE ABDOMEN; ACUTE DISEASE; ACUTE PANCREATITIS; ADULT; ANTIBIOTIC THERAPY; APPENDICITIS; ARTHRITIS; ARTICLE; BACKACHE; BLEEDING; BLOODY DIARRHEA; CASE REPORT; CHOLELITHIASIS; CHRONIC PAIN; COLON BIOPSY; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CONSTIPATION; DECREASED APPETITE; DESCENDING COLON; DIAPHORESIS; DIARRHEA; DISEASE SEVERITY; DYSPEPSIA; DYSPHAGIA; EMERGENCY WARD; EPIGASTRIC DISCOMFORT; EXUDATE; FEMALE; FOLLOW UP; GASTRITIS; GASTROENTERITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HEALING; HEMATEMESIS; HEMORRHOID; HIATUS HERNIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERSALIVATION; HYPERTENSION; INTESTINE ISCHEMIA; IRRITABLE COLON; ISCHEMIC COLITIS; LEUKOCYTOSIS; LIVER DISEASE; LONG TERM CARE; LOWER ABDOMINAL PAIN; MALABSORPTION; MALE; MASTICATION; MIDDLE AGED; MIGRAINE; MUCOSAL BLEEDING; MUSCLE SPASM; NAUSEA; NEUROGENIC BOWEL; NUCLEAR MAGNETIC RESONANCE IMAGING; PALPATION; PANCREAS DUCT STENOSIS; PANCREAS INJURY; PANCREATITIS; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; RECTUM HEMORRHAGE; RECTUM INJURY; REFLUX ESOPHAGITIS; REPEAT PROCEDURE; RETURN TO WORK; SCAR FORMATION; SIDE EFFECT; SIGMOID; STOMACH DISEASE; STOMACH HEMORRHAGE; STOMACH ULCER; TENESMUS; TRANSVERSE COLON; ULCER; ULCERATIVE COLITIS; UPPER ABDOMINAL PAIN; VASOSPASM; VOMITING;

ADVERSE DRUG REACTION REPORTING SYSTEMS; COLITIS, ISCHEMIC; COLONOSCOPY; HUMANS; INTESTINAL MUCOSA; SEROTONIN 5-HT1 RECEPTOR AGONISTS; SUMATRIPTAN;

EID: 84897948842     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.1007/s40264-013-0134-7     Document Type: Article

References (53)

1. Brandt LJ, Feuerstat P, Blaszka MS. Anatomic patterns, patient characteristics and clinical outcomes in ischemic colitis: a study of 313 cases supported by histology. Am J Gastroenterol. 2010;105(10):2245-52.
2. Gandhi SK, Hanson MM, Vernava AM, et al. Ischemic colitis. Dis Colon Rectum. 1996;39(1):88-100.
3. Higgins PD. Systematic review: the epidemiology of ischaemic colitis. Aliment Pharmacol Ther. 2004;19(7):729-38.
4. Longstreth GF, Yao JF. Epidemiology, clinical features, high-risk factors, and outcome of acute large bowel ischemia. Clin Gastroenterol Hepatol. 2009;7:1075-80.
5. Longstreth GF, Yao JF. Diseases and drugs that increase risk of acute large bowel ischemia. Clin Gastroenterol Hepatol. 2010;8:49-54.
6. Lewis JH. The risk of ischaemic colitis in irritable bowel syndrome patients treated with serotonergic therapies. Drug Saf. 2011;34:545-65.
7. Suh DC, Kahler KH, Choi IS, Shin H, Kralstein J, Shetzline M. Patients with irritable bowel syndrome or constipation have an increased risk for ischaemic colitis. Aliment Pharmacol Ther. 2007;25:681-92.
8. Knudsen JF, Friedman B, Chen M, Goldwasser JE. Ischemic colitis and sumatriptan use. Arch Intern Med. 1998;158:1946-8.
9. Caekebeke JF, Ferrari MD, Zwetsloot CP, Jansen J, Saxena PR. Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks. Neurology. 1992;42:1522-6.
10. Friberg L, Olesen J, Iversen HK, Sperling B. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet. 1991;338:13-7.
11. Naik M, Potluri R, Almasri E, Arnold G. Sumatriptan-associated ischemic colitis. Dig Dis Sci. 2002;47:2015-6.
12. Moawad FJ, Goldkind L. An unusual case of colonic ischemia. South Med J. 2009;102:405-7.
13. Hodge JA, Hodge KD. Ischemic colitis related to sumatriptan overdose. JABFM. 2010;23:124-7.
14. Liu JJ, Ardolf JC. Sumatriptan-associated mesenteric ischemia. Ann Intern Med. 2000;132:597.
15. Alkhatib AA, Gangotena F, Peterson KA. Rizatriptan induced acute on top of chronic ischemic colitis. Am J Gasterolenterol. 2009;104:2643-4.
16. Schwartz DC, Smith DJ. Colonic ischemia associated with naratriptan use. J Clin Gastroenterol. 2004;38:790-2.
17. Charles JA, Pullicino PM, Stoopack PM, Shroff Y. Ischemic colitis associated with naratriptan and oral contraceptive use. Headache. 2005;45:386-9.
18. Westgeest HM, Akol H, Schreuder CMA. Pure naratriptaninduced ischemic colitis: a case report. Turk J Gastroenterol. 2010;21:42-4.
19. Chang L, Tong K, Ameen V. Ischemic colitis and complications of constipation associated with the use of alosetron under a risk management plan: clinical characteristics, outcomes, and incidences. Am J Gastroenterol. 2010;105:866-75.
20. Gallo-Torres H, Brinker A, Avigan M. Alosetron: ischemic colitis and serious complications of constipation. Am J Gastroenterol. 2006;101:1080-3.
21. DeBaise JK. Tegaserod-associated ischemic colitis. Pharmacotherapy. 2005;25:620-5.
22. Cappell MS. Colonic toxicity of administered drugs and chemicals. Am J Gastroenterol. 2004;99:1175-90.
23. Kleespies A, Jonas S, Neuhaus P. Simulation of colon carcinoma: diuretic induced ulcerative-stricturing ischemic colitis. Dtsch Med Wochenschr. 2004;129(13):681-4.
24. Linder JD, Monkemuler KE, Raijman I, et al. Cocaine-associated ischemic colitis. South Med J. 2000;93:909-13.
25. Montgomery EM, Riddell RH. Ischemic colitis in a young patient. Pathol Case Rev. 2004;9:93-6.
26. Keller HW, Lorenz R, Mueller JM, Pichmaier H. Ischemic colitis following digitalis poisoning. Chirurg. 1984;55(12):830-1.
27. Ablassmaier B, Hartmann JA. Case of severe ischaemic colitis following non- steroidal anti-inflammatory drug intake. Zentralbl Chir. 2004;129(6):510-2.
28. Deana DG, Dean PJ. Reversible ischemic colitis in young women in association with oral contraceptive use. Am J Surg Pathol 19 (1995): :454-62.
29. Giurbuz AK, Gurbuz B, Salas L, Rosenshein NB, Donowitz M, Giardiello FM. Premarin induced ischemic colitis. J Clin Gastro. 1994;19:108-11.
30. Preventza OA, Lazarides K, Sawyer MD. Ischemic colitis in young adults: a single-institution experience. J Gastrointest Surg. 2001;5:388-92.
31. Salk A, Stobaugh DJ, Deepak P, Ehrenpreis ED. Ischaemic colitis in rheumatoid arthritis patients receiving tumor necrosis factor-a inhibitors: an analysis of reports to the US FDA Adverse Event Reporting System. Drug Saf. 2013;36:329-34.
32. Salk A, Stobaugh DJ, Deepak P, Ehrenpreis ED. Ischemic colitis with type 1 interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the Food and Drug Administration Adverse Event Reporting System and review of the literature. Ann Pharmacother. 2013;47:537-42.
33. Rodman RE, Willson TD, Connolly MM, Podbielski FJ. Ischemic colitis secondary to ergotamine use: a case study. Case Rep Gastroenterol. 2011;5:1-4.
34. Rashid A, Hamilton SR. Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate in sorbitol: an underrecognized condition. Am J Surg Pathol. 1997;21:60-9.
35. Traino A, Buckley M, Bassett M. Probable ischemic colitis caused by pseudoephedrine with tramadol as a possible contributing factor. Ann Pharmacother. 2004;38:2068-70.
36. Camerilli M. Is there an experimental basis for the development of ischaemic colitis as a result of 5-HT3 antagonist treatment? Neurogastroenterol Motil. 2007;19:77-84.
37. Millson D, Sohail S, Lettis S, et al. Duration of inihibition of the flare response to intradermal 5-hydroxytryptamine in man by GR68755, an novel specific 5-HT3 receptor antagonist. Br J Clin Pharmacol. 1992;33:546-7.
38. Limmroth V, May A, Auerbach P, Wosnitza G, Eppe T, Diener HC. Changes in cerebral blood flow velocity after treatment with sumatriptan or placebo and implications for the pathophysiology of migraine. J Neurol Sci. 1996;138(1-2):60-5.
39. Ringle Y, Wilson J, D'Agostino R, Lewis JH. Development and validation of an ischemic colitis clinical diagnosis assessment instrument. Gastroenterology 2005;128.4 (Suppl 2):A467.
40. Imitrex tablets prescribing information, 2012. GlaxoSmithKline Research Triangle Park, NC 27709. http://us.gsk.com/products/ assets/us-imitrex-tablets. pdf Accessed 7 Dec 2013.
41. Amerge (naratriptan hydrochloride) tablets prescribing information, October 2013. GlaxoSmithKline Research Triangle Park, NC 27709. http://us.gsk.com/products/assets/us-amerge. pdf. Accessed 7 Dec 2013.
42. Maxalt (rizatriptan benzoate) prescribing information, January 2013. Merck & Co. Whitehouse Station, NJ 08889. http://www. merck.com/product/usa/ pi-circulars/m/maxalt/maxalt-pi.pdf. Accessed 7 Dec 2013.
43. Relpax (eletriptan hydrobromide) tablets prescribing information, May 2008; Roerig Division of Pfizer, NY,NY 10017. http:// dailymed.nlm.nih.gov/ dailymed/lookup.cfm?setid=986dc112-b97b- 44a3-bfaf-074f906f8bb2. Accessed 7 Dec 2013.
44. Axert (almotriptan malate) tablets prescribing information, April 2011; Ortho-McNeil Neurologics, Titusville, NJ 08560. http:// dailymed.nlm.nih.gov/ dailymed/lookup.cfm?setid=b13ba9bf-1661- 456a-8eae-6d110ea08c94. Accessed 7 Dec 2013.
45. Frova (frovatriptan succinate) prescribing information, April 2007; Endo Pharmaceuticals, Inc. 100 Endo Blvd, Chadds Ford, PA 19317. http://dailymed.nlm. nih.gov/dailymed/lookup.cfm? setid=294d60f3-005b-40d9-a404-cdd77f62b820. Accessed 7 Dec 2013.
46. Zomig (zolmitriptan) prescribing information, September 2012; AstraZeneca/Impax Pharmaceuticals, Hawward, CA 94544. http://dailymed.nlm.nih. gov/dailymed/lookup.cfm?setid=294d60 f3-005b-40d9-a404-cdd77f62b820. Accessed 7 Dec 2013.
47. Personal communication, JP Nicandro. Data on file with Prometheus Laboratories, San Diego, CA.
48. Loder E. Triptan therapy in migraine. N Engl J Med. 2010;363:63-70.
49. Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs. 2000;60:1259-87.
50. Bax WA, Renzenbrink GJ, Van Heuven-Nolsen D, Thijssen EJ, Bos E, Saxena PR. 5-HT receptors mediating contractions of the isolated human coronary artery. Eur J Pharmacol. 1993;239: 203-10.
51. Connor HE, Feniuk W, Humphrey PP. 5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation. Eur J Pharmacol. 1989;161:91-4.
52. Jamieson DG. The safety of triptans in the treatment of patients with migraine. Am J Med. 2002;112:135-40.
53. Szarfman A, Machado SG, O'Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-thanexpected combinations of drugs and events in the US FDA's spontaneous reports database. Drug Saf. 2002;25(6):381-92.